Craig T. Jordan

Dr. Jordan completed his bachelor’s degree at the University of California, Berkeley, followed by doctoral studies at Princeton University with a focus on the molecular biology of hematopoietic stem cells. He then went on to perform post-doctoral studies at MIT’s Whitehead Institute. He next spent several years working in the biotechnology industry before rejoining the academic ranks in 1997 at the University of Kentucky as an Assistant Professor of medicine. In 2003 he moved to the University of Rochester, where he became the Director of Translational Research for Hematologic Malignancies at the James P. Wilmot Cancer Center. In 2013 he was recruited to his present position at the University of Colorado Denver. Dr. Jordan has been and is an editorial board member or academic editor for several journals including Leukemia, Stem cells, PLoS Biology, Blood, and Cell Stem Cell, and is ad hoc reviewer for numerous journals including Science, Nature, New England Journal of Medicine, Nature Medicine, Cancer Cell, Nature Reviews Cancer, Lancet, Nature Reviews Drug Discovery, Drug Discovery Today, etc. Dr. Jordan has participated in numerous NIH/NCI grant review panels, and has published over 125 peer-reviewed original research articles, review articles and book chapters. He has successfully maintained national level grants including awards from the NIH/NCI, Department of Defense, Leukemia and Lymphoma Society, and American Cancer Society. His honors include the Helen Hay Whitney Fellowship, the Stohlman Scholar Award from the Leukemia and Lymphoma Society, and the Philip and Marilyn Wehrheim endowed chair in cancer research.